marginally significantP = .07
Among the APOE ε4–negative subjects, ADAS 11 presented a marginally significant difference in mean change from baseline between statin users and nonusers (statin positive = −0.18 vs. statin negative = −0.93, P = .07).
Among the APOE ε4–negative subjects, ADAS 11 presented a marginally significant difference in mean change from baseline between statin users and nonusers (statin positive = −0.18 vs. statin negative = −0.93, P = .07).
Change reached marginal significance on the ADAS 11 when stratified by APOE ε4–negative subjects.